Adam Urato: Understanding SSRI Impacts on Maternal and Fetal Serotonin Levels
Adam Urato, Maternal-Fetal Medicine Physician at MetroWest Medical Center, shared a post on X about a recent article by Amy L. Salisbury et al., published in Neuropsychopharmacology, adding:
“Remember, SSRIs have a profound chemical impact on a pregnant mom and her baby.
Platelet serotonin levels are dramatically lower for both and it’s likely there are similar effects in the brain, since SSRIs block the serotonin transporter (present in the brain and platelets).”
Title: Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect
Authors: Amy L. Salisbury, George M. Anderson, Amy Yang, Catherine S. Stika, Laura J. Rasmussen-Torvik, Jacqueline K. Gollan, Katherine L. Wisner
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 13:11Ayshathul Noora։ Carbetocin vs Oxytocin in Preventing Postpartum Hemorrhage
-
Oct 9, 2026, 13:07The Rebalanced Patient: New Therapies and New Thrombotic Risks in Hemophilia
-
Oct 9, 2026, 12:48Santiago Cepeda Chafla: CereBleed Simplifies Brain Hemorrhage Assessment
-
Oct 9, 2026, 12:34Abdul Muqtadir Abbasi: Pancytopenia Is a Finding, Not a Diagnosis
-
Oct 9, 2026, 12:24Mercy Lung’aho: When Diet Quality and Nutritional Biomarkers Tell Different Stories
-
Oct 9, 2026, 12:22Eugene Fan: Bridging Therapeutic Breakthroughs and Equitable Thalassaemia Care
-
Oct 9, 2026, 12:14Brittany Busse: A New Focus on Iron Deficiency Before Anemia
-
Oct 9, 2026, 12:13Akshat Jain: A New Textbook Bringing Global Perspectives on Sickle Cell Disease
-
Oct 9, 2026, 12:03Heather Case: Bridging Awareness and Action in Women’s Hemophilia Care